Parvo preventative picks up speedDecember 29, 2020Elanco Animal Health is set to acquire the global rights to Kindred Biosciences’ proprietary KIND-030, a monoclonal antibody being developed for the treatment and prevention of canine parvovirus.
SPONSORED CONTENTLet's help them fight the urge to itchHill’s Derm Complete is formulated to help reduce allergic responses, including licking, scratching, headshaking and skin redness + Tell Me More